Current Health, which offers the leading FDA-cleared, artificial intelligence (AI)-powered patient management platform, today announced that it will collaborate with Massachusetts General Hospital (MGH) and the Mbarara University of Science and Technology (MUST) in a study aimed at reducing maternal deaths and severe complications following cesarean delivery in Sub-Saharan Africa. Through the initiative – funded by the National Institutes of Health and led by Adeline Boatin, MD, MPH, lead investigator and physician in the department of Obstetrics, Gynaecology at MGH, and Joseph Ngonzi, MBChB, senior lecturer in the Department of Obstetrics and Gynaecology, Faculty of Medicine at MUST – Current Health will provide its patient management platform to healthcare providers at Uganda’s Mbarara Regional Referral Hospital. Providers will use Current Health’s solution to more closely manage patients after caesarean delivery with the goal of improving detection of potential crisis following childbirth. Together, Current Health, MGH and MUST aim to provide improved care to 1,235 women in the first 12-24 months of the study.
In sub-Saharan Africa, a woman faces a 1 in 37 chance of dying due to pregnancy or childbirth-related complication, the highest maternal mortality rate globally. This accounts for more than two-thirds of all maternal deaths worldwide each year. Many of these deaths are preventable, especially those that occur within 24 hours of a cesarean delivery. But with an extreme shortage of healthcare providers – in 2013, sub-Saharan Africa had a deficit of an estimated 1.8 million health workers – detecting childbirth issues before they become crises can be extremely challenging.
With a focus on using technology and innovation to identify patients at risk of deterioration – especially in environments with a poor staff-to-patient ratio – Current Health is uniquely positioned to tackle this pervasive issue. The Current Health platform provides real-time patient data to healthcare providers, enabling doctors and nurses to monitor a patient’s condition no matter where they are located. With this information, healthcare providers can prioritize care to those at the highest risk of deterioration.
“Ensuring that all women have access to quality healthcare no matter where they live is deeply important,” said Dr. Boatin. “By studying the use of patient management technology, we hope to identify the role it may play in improving healthcare in resource-limited settings and preventing maternal death and complications.”
“Current Health’s mission is to create a world where no one dies from a preventable death and where healthcare is proactive, not reactive,” said Chris McCann, CEO, Current Health. “With this study, we immediately recognized an opportunity to make an enormous and positive impact on healthcare in this region. Our technology may be ideally suited to the rural environment of sub-Saharan Africa, monitoring the vitals of postpartum women to ensure they remain in stable condition after giving birth. With Drs. Boatin and Ngonzi and their team, we believe that we can have an incredible impact.”
To learn more about Current Health and its integrated platform, visit www.currenthealth.com.
About Current Health
Current Health provides the leading FDA-cleared, artificial intelligence (AI)-powered patient management platform. Driven by continuous wearable and wireless vital signs monitoring, as well as an ecosystem of integrations and patient engagement tools, Current Health’s platform offers healthcare providers the real-time insights they need to make proactive and informed decisions about patient care. As a result, providers can improve patient outcomes and experiences, while reducing the cost of healthcare delivery. For more information, visit https://www.currenthealth.com/ and follow us on Twitter and LinkedIn.
Contacts
Version 2.0 Communications
Victoria Newell, 617-426-2222
currenthealth@v2comms.com 00000000